Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

ppd logo

Categories Won:

  1. Quality

  2. Reliability

  3. Regulatory

  4. Productivity

  5. Innovation

 

Drug Life Cycle Stages:

Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)

Main Service Areas:
Bioanalytical, Clinical, Preclinical

Services & Capabilities:
Preclinical: discovery (BioDuro and X-Chem), nonclinical; Clinical: Phase I, Phase II-IIIb and  post-approval; therapeutic and specialty expertise; clinical data management/IT ; consulting; Laboratory Services — bioanalytical labs; cGMP labs; central labs; vaccines and biologics

Therapeutic Areas:
Cardiovascular, critical care, dental pain research, dermatology, endocrine and metabolic,  gastroenterology, hematology and oncology, immunology, infectious diseases, neuroscience, ophthalmology, respiratory, urology

William Sharbaugh

chief operating officer

“PPD ’s innovative solutions bend the cost and time curve of drug discovery and development to create value for biopharmaceutical clients, resulting in the delivery of life-changing therapies in a faster, more cost-effective manner. Our clients benefit from PPD ’s world-class scientific expertise, innovative technology, flexible service models, and operational efficiencies at every stage of the drug discovery and development continuum. We recognize that developing, engaging, and empowering our employees are keys to successful performance for our clients. Our people truly make the difference.”